Abstract
Ectromelia virus infections in the laboratory mouse have emerged as a valuable model to investigate human orthopoxvirus infections to understand the progression of disease, to discover and characterize antiviral treatments, and to study the host–pathogen relationship as it relates to pathogenesis and the immune response. Here we describe how to safely work with the virus and protocols for common procedures for the study of ectromelia virus in the laboratory mouse including the preparation of virus stocks, the use of various routes of inoculation, and collection of blood and tissue from infected animals. In addition, several procedures are described for assessing the host response to infection: for example, measurement of virus-specific CD8 T cells and the use of ELISA and neutralization assays to measure orthopoxvirus-specific antibody titers.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Parker S, Nuara A, Buller RML, Schultz DA (2007) Human monkeypox: an emerging zoonotic disease. Future Microbiol 2:17–34
Henderson DA (1999) The looming threat of bioterrorism. Science 283:1279–82
Fenner F, Henderson DA, Arita I, Jezek Z, Ladnyi ID (1988) Smallpox and its eradication. World Health Organization, Geneva
Saini D, Buller RM, Biris AS, Biswas P (2009) Characterization of a nose-only Inhalation exposure system for ectromelia virus infection of mice. Particulate Sci Technol 27: 152–65
Hostetler KY, Beadle JR, Trahan J et al (2007) Oral 1-O-octadecyl-2-O-benzyl-sn-glycero-3-cidofovir targets the lung and is effective against a lethal respiratory challenge with ectromelia virus in mice. Antiviral Res 73:212–8
Parker AK, Parker S, Yokoyama WM, Corbett JA, Buller RML (2007) Induction of natural killer cell responses by ectromelia virus controls infection. J Virol 81:4070–9
Buller RML, Fenner F (2007) Mousepox. In: Fox JG, Barthold SW, Davisson MT, Newcomer CE, Quimby FW, Smith AL (eds) The mouse in biomedical research. Elsevier, New York, pp 67–92
Esteban DJ, Buller RML (2005) Ectromelia virus: the causative agent of mousepox. J Gen Virol 86:2645–59
Palumbo GJ, Buller RML (1991) Inhibitors of the lipoxygenase pathway specifically block orthopoxvirus replication. Virology 180: 457–63
Brownstein DG, Bhatt PN, Gras L, Jacoby RO (1991) Chromosomal locations and gonadal dependence of genes that mediate resistance to ectromelia (mousepox) virus-induced mortality. J Virol 65:1946–51
Delano ML, Brownstein DG (1995) Innate resistance to lethal mousepox is genetically linked to the NK gene complex on chromosome 6 and correlates with early restriction of virus replication by cells with an NK phenotype. J Virol 69:5875–7
Brownstein DG, Gras L (1997) Differential pathogenesis of lethal mousepox in congenic DBA/2 mice implicates natural killer cell receptor NKR-P1 in necrotizing hepatitis and the fifth component of complement in recruitment of circulating leukocytes to spleen. Am J Pathol 150:1407–20
Schell K (1960) Studies on the innate resistance of mice to infection with mousepox. II. Route of inoculation and resistance, and some observations on the inheritance of resistance. Aust J Exp Biol Med Sci 38:289–99
Jacoby RO, Bhatt PN (1987) Mousepox in inbred mice innately resistant or susceptible to lethal infection with ectromelia virus. II. Pathogenesis. Lab Anim Sci 37:16–22
Bhatt PN, Jacoby RO (1987) Mousepox in inbred mice innately resistant or susceptible to lethal infection with ectromelia virus. I. Clinical responses. Lab Anim Sci 37:11–5
Bhatt PN, Jacoby RO, Gras L (1988) Mousepox in inbred mice innately resistant or susceptible to lethal infection with ectromelia virus. IV. Studies with the Moscow strain. Arch Virol 100:221–30
Wallace GD, Buller RM (1985) Kinetics of ectromelia virus (mousepox) transmission and clinical response in C57BL/6j. BALB/cByj and AKR/J inbred mice. Lab Anim Sci 35:41–6
Wallace GD, Buller RML, Morse HC III (1985) Genetic determinants of resistance to ectromelia (mousepox) virus-induced mortality. J Virol 55:890–1
Schriewer J, Buller RM, Owens G (2004) Mouse models for studying orthopoxvirus respiratory infections. Methods Mol Biol 269:289–308
Earl PL, Moss B, Wyatt LS, Carroll MW (2001) Generation of recombinant vaccinia viruses, Chapter 16. In: Ausubel FM (ed) Current protocols in molecular biology
Forbes N, Brayton C, Grindle S, Shepherd S, Tyler B, Guarnieri M (2010) Morbidity and mortality rates associated with serial bleeding from the superficial temporal vein in mice. Lab Anim (NY) 39:236–40
Zhang Z, Kermekchiev MB, Barnes WM (2010) Direct DNA amplification from crude clinical samples using a PCR enhancer cocktail and novel mutants of Taq. J Mol Diagn 12:152–61
Acknowledgments
This work was supported by a subcontract N01-AI-30063 to Southern Research.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Esteban, D., Parker, S., Schriewer, J., Hartzler, H., Buller, R.M. (2012). Mousepox, A Small Animal Model of Smallpox. In: Isaacs, S. (eds) Vaccinia Virus and Poxvirology. Methods in Molecular Biology, vol 890. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-876-4_11
Download citation
DOI: https://doi.org/10.1007/978-1-61779-876-4_11
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61779-875-7
Online ISBN: 978-1-61779-876-4
eBook Packages: Springer Protocols